<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05629975</url>
  </required_header>
  <id_info>
    <org_study_id>SBKT-2022-201</org_study_id>
    <nct_id>NCT05629975</nct_id>
  </id_info>
  <brief_title>Oral Nutritional Supplements in Treatment of Elderly Mild-to-Moderate COVID-19</brief_title>
  <acronym>ONSITEMC</acronym>
  <official_title>Department of Thoracic Surgery, Shanghai Tongji Hospital, School of Medicine, Tongji University, Xincun Rd. 389, Shanghai, 200065, People's Republic of China.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Tongji Hospital, Tongji University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Tongji Hospital, Tongji University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The coronavirus disease 2019 (COVID-19) pandemic has seriously threatened public health&#xD;
      worldwide. Nutritional supplements may have a positive influence on the recovery of patients&#xD;
      with viral infection. This study aimed to assess the influence of oral nutritional&#xD;
      supplements (ONSs) on the biochemical parameters of elderly patients with mild-to-moderate&#xD;
      COVID-19.&#xD;
&#xD;
      This clinical trial will be conducted on 145 elderly patients with mild-to-moderate COVID-19.&#xD;
      Patients in the intervention group (n=74) received nutritional powder (vitamins, minerals,&#xD;
      dietary fiber, polyphenols, omega-3, amino acids, and probiotics) for 14 days. Cases in the&#xD;
      control group (n=71) took the placebo, except for nutritional powder, and they received the&#xD;
      same treatment. Biochemical parameters were measured before and two weeks after intervention.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The coronavirus disease 2019 (COVID-19) pandemic has seriously threatened public health&#xD;
      worldwide. Nutritional supplements may have a positive influence on the recovery of patients&#xD;
      with viral infection. This study aimed to assess the influence of oral nutritional&#xD;
      supplements (ONSs) on the biochemical parameters of elderly patients with mild-to-moderate&#xD;
      COVID-19.&#xD;
&#xD;
      This clinical trial will be conducted on 145 elderly patients with mild-to-moderate COVID-19.&#xD;
      Patients in the intervention group (n=74) received nutritional powder (vitamins, minerals,&#xD;
      dietary fiber, polyphenols, omega-3, amino acids, and probiotics) for 14 days. Cases in the&#xD;
      control group (n=71) took the placebo, except for nutritional powder, and they received the&#xD;
      same treatment. Biochemical parameters were measured before and two weeks after intervention.&#xD;
&#xD;
      After 14 days, patients in the groups will be measured by C-reactive protein (CRP),&#xD;
      creatinine (Cr), blood urea nitrogen (BUN), and interleukin-8 (IL-8) ,white blood cell (WBC),&#xD;
      red blood cell (RBC), platelet (PLT), neutrophil percentage (NE%), prothrombin time (PT),&#xD;
      D-Dimer (DD), blood glucose, sodium (Na+), potassium (K+), aspartate aminotransferase (AST),&#xD;
      glutamate pyruvic transaminase (ALT), albumin, calcium (Ca), arterial blood gas (ABG)&#xD;
      parameters, and interleukin-10 (IL-10).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 30, 2022</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>coagulation function and blood cell count (CBC)</measure>
    <time_frame>2 weeks</time_frame>
    <description>white blood cell (WBC) count(*109/L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>kidney functions</measure>
    <time_frame>2 weeks</time_frame>
    <description>blood urea nitrogen (BUN)(mg/L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ABG parameters</measure>
    <time_frame>2 weeks</time_frame>
    <description>oxygen partial pressure (PO2)(mmHg)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>serum electrolytes</measure>
    <time_frame>2 weeks</time_frame>
    <description>potassium (K+)(mmol/L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>inflammatory indices</measure>
    <time_frame>2 weeks</time_frame>
    <description>interleukin-8 (IL-8)(pg/mL)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Nutrition, Healthy</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In addition to the normal diet in the hospital, patients in the intervention group received a package of nutritional powder in the morning and evening of every day, and each package was diluted with 500 ml of water.&#xD;
Each package contained L-arginine (750 mg), methionine (300 mg), glutamine (5 g), plant protein (10 g), vitamin B12 (1 ug), vitamin C (50 mg), vitamin D (2000 IU), vitamin A (300 mg), folic acid (5 mg), omega-3 fatty acid (1 g), zinc (20 mg), magnesium (400 mg), selenium (100 mcg), whole wheat fiber (5 g), carotenoid (3 mg), curcumin supplement (500 mg).&#xD;
Probiotics included orally administration of clostridium butyricum&amp; bifidobacterium (500 mg) every day for 7 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients in the control group received normal diet provided by the hospital.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Oral Nutritional Supplements</intervention_name>
    <description>Each package contained L-arginine (750 mg), methionine (300 mg), glutamine (5 g), plant protein (10 g), vitamin B12 (1 ug), vitamin C (50 mg), vitamin D (2000 IU), vitamin A (300 mg), folic acid (5 mg), omega-3 fatty acid (1 g), zinc (20 mg), magnesium (400 mg), selenium (100 mcg), whole wheat fiber (5 g), carotenoid (3 mg), curcumin supplement (500 mg).&#xD;
Probiotics included orally administration of clostridium butyricum&amp; bifidobacterium (500 mg) every day for 7 days.</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. COVID-19-positive was confirmed by reverse transcription-polymerase chain reaction&#xD;
             (RT-PCR);&#xD;
&#xD;
          2. Mild-to-moderate COVID-19 patients who aged 60-90 years old;&#xD;
&#xD;
          3. Consistency with the indication of enteral nutrition;&#xD;
&#xD;
          4. The time from diagnosis of COVID-19 to hospitalization was less than 24 h.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Oxygen saturation &lt; 93% or mechanical ventilation was required;&#xD;
&#xD;
          2. Systemic diseases (malignant tumors, autoimmune diseases, liver or kidney diseases);&#xD;
&#xD;
          3. Participation in other clinical trials within 3 months;&#xD;
&#xD;
          4. History of allergy to nutrients in the trial.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yongxin Zhou, Dr</last_name>
    <role>Study Chair</role>
    <affiliation>Shanghai Tongji Hospital, Tongji University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wenli Wang, Dr</last_name>
    <phone>13761295864</phone>
    <email>anderson840913@163.com</email>
  </overall_contact>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 3, 2022</study_first_submitted>
  <study_first_submitted_qc>November 23, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 29, 2022</study_first_posted>
  <last_update_submitted>November 23, 2022</last_update_submitted>
  <last_update_submitted_qc>November 23, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 29, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Tongji Hospital, Tongji University School of Medicine</investigator_affiliation>
    <investigator_full_name>Yongxin Zhou</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <keyword>Oral nutritional supplements</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

